Receive Promise magazine online to learn about the innovative research and excellent medical care happening at St. Jude. Your free subscription will start with our next quarterly issue of Promise.
In this issue . . .
Something to Dance About: A Gentler Approach to Transplants
Using a gentler chemotherapy and radiation conditioning regimen, the Sickle Cell Disease Hematopoietic Cell Transplantation (SCDHCT) study aims to cure children with severe sickle cell disease and reduce side effects and subsequent health issues.
The 2022–27 St. Jude Strategic Plan: Accelerating Progress Globally
Learn how St. Jude can uniquely accelerate progress to advance cures, and means of prevention, for pediatric catastrophic diseases through fundamental science, global impact, and workforce and environment.
von Hippel-Lindau: Focusing on an Invisible Foe
As a von Hippel-Lindau Clinical Care Center, St. Jude can focus the treatment experience for families affected by the rare genetic disorder.
Sharing High-tech Tools with the World
Scientists at St. Jude work behind the scenes – finding faster and better ways to sift through DNA data and save the lives of children around the world.
Shining a Light on Mucositis
Light therapy, or photobiomodulation therapy, is a painless and potential solution to reduce oral mucositis in children and adolescents who have had bone marrow transplantation.
A Global View of ALL
St. Jude takes steps to improve the outlook for children with acute lymphoblastic leukemia in China and around the world.
Treatment Refinements Offer Global Benefits
Results from clinical trials in Recife, Brazil, and Cairo, Egypt, offer hope to children in low- and middle-income countries worldwide.
Life after St. Jude: ‘Cured’ Is Only the Beginning
Childhood cancer survivor Katie Chinn Weyer learns to navigate life —and her health — after treatment.
News & Highlights - Summer 2021
Explore some of the latest clinical and scientific research from St. Jude, including medulloblastoma, COVID-19 and data sharing.